How to Relieve Constipation on Semaglutide?

How to Relieve Constipation on Semaglutide: Matching the Fix to the Cause

Water, fiber, movement, and short-term OTC laxatives cover most semaglutide-related constipation, but reaching for all four at once misses the point. Which one actually helps first depends on what's driving your particular case, and new, mild backup during a dose increase calls for a different starting move than constipation that's been dragging on for weeks.

What's Driving Your Constipation

Semaglutide delays gastric emptying, how fast food leaves your stomach, as part of how the drug works, and that's documented directly on the label.¹ Whether that also slows things further down the digestive tract is less settled: researchers who pooled semaglutide's GI trial data have floated slower lower-GI transit as a possible explanation for the constipation, but say the evidence for it is still lacking.² Separately, semaglutide tends to curb appetite enough that many people eat and drink less than they used to. A slower stomach and a smaller appetite are two different effects, but they push in the same direction, and it's a big part of why generic "drink more water" advice doesn't always fully solve it on its own.

Constipation also tends to stick around longer than semaglutide's other GI complaints. In a pooled analysis across three major trials, funded by Novo Nordisk with several Novo Nordisk employees and shareholders among the authors, the median constipation episode lasted 47 days in the semaglutide group versus 35 days on placebo, compared with just 8 days for nausea and 3 days for diarrhea.² If the basics haven't helped after several days, that's a reasonable point to add another option rather than wait it out.

Start With Water: When Hydration Is Enough

Not drinking enough fluid is one of the risk factors for constipation that NIDDK lists in general, alongside low fiber intake and low activity.³ It's an easy one to fall behind on when nausea or a smaller appetite means you're skipping meals, and the fluids that used to come with them.

If your constipation is new, mild, and shows up mainly around dose increases, this is the right place to start: pair any fiber increase with extra water, and pay attention to whether you're actually drinking less than before. There isn't a semaglutide-specific hydration trial behind this recommendation; it's a general, common-sense measure rather than one with its own dedicated evidence base, so don't expect it to resolve constipation that's already been dragging on for weeks.

Whole-Food Fiber vs. Fiber Supplements: Which First

Most US adults fall short of fiber recommendations even without a GLP-1 medication cutting their food volume. In a nationwide dataset covering 2013-2018 (over 14,000 adults), only about 7.4% met the adequate intake for fiber, measured as 14 g per 1,000 calories eaten rather than a flat daily gram target; that figure has only been presented at a nutrition conference rather than published as a full peer-reviewed paper.⁴ The targets most guidelines use are 25 g/day for women under 51 and 21 g/day for women 51 and older.⁵

Food-first fiber, vegetables, beans, whole grains, and fruit with the skin on, is the reasonable starting point if you can still eat enough volume to get there. Semaglutide's appetite-suppressing effect works directly against that: if you're satisfied after a few bites, eating your way to 25 grams of fiber gets hard fast.

A fiber supplement is a reasonable way to close that gap without depending on appetite alone. A 2022 systematic review of 16 randomized trials (1,251 people with chronic constipation) found fiber supplementation significantly increased stool frequency (SMD 0.72, 95% CI 0.36-1.08, P=.0001, from 14 of those trials).⁶ In a separate sensitivity analysis that converted a subset of 12 trials (966 people) into a shared unit, fiber added about 1.19 bowel movements per week (95% CI 0.59-1.78, P<0.0001). A psyllium-specific subgroup within that same analysis showed a larger add of about 3.08 bowel movements per week (95% CI 0.61-5.54, P=.01), though that subgroup carries high statistical heterogeneity (I²=90%).⁶ The same review found fiber didn't significantly worsen bloating severity, but it did significantly worsen flatulence severity, a tradeoff worth knowing before you start.⁶

Not all fibers ferment at the same speed. A lab-based (in vitro) fermentation study of wheat dextrin, inulin, and PHGG, funded by Novartis Consumer Health with a company employee among the authors, found wheat dextrin fermented slowest and produced the least gas, inulin-type fructans (the same chemical family as FOS) fermented fastest and produced the most gas, and PHGG fell in between.⁷ It's a mechanistic finding from one specific study, not a test of any finished product; it didn't include Fibersol, psyllium, or FOS directly.

WonderBiotics Daily Fiber Mix combines partially hydrolyzed guar gum, the fiber the study above tested directly and found to ferment at an intermediate rate, with Fibersol soluble corn fiber, a different manufacturer's resistant fiber not tested in that study but generally grouped in the same slower-fermenting category as wheat dextrin, alongside psyllium husk, kale fiber, and FOS for its prebiotic effect. FOS itself is a fast fermenter, kept in the formula for that prebiotic role, which is why the 6 g sachets are dosed to start at one per day and build up only as you tolerate it.

Do Probiotics Help With Semaglutide Constipation

Bifidobacterium animalis subsp. lactis HN019 is one of the more studied single strains for bowel regularity, with four placebo-controlled trials published so far, none of which enrolled people taking a GLP-1 medication.

The earliest, a 2011 dose-ranging trial, randomized 100 adults with infrequent bowel movements (33 high-dose, 33 low-dose, 34 placebo, with 88 completing paired transit-time measurements after uneven dropout across arms). The high dose (17.2 billion CFU/day) produced a significant within-group drop in mean transit time, from 49 to 21 hours (P<.001), and the three-arm difference in that change was significant by ANOVA as well (P<.001). In a separate Kaplan-Meier analysis of how quickly ingested markers were fully excreted, the high-dose group also cleared them significantly faster than both the low-dose and placebo groups (P<.05).⁸ That's the strongest single result of the four, and it's also the smallest and oldest trial, funded by Fonterra Research Centre, with three of the seven authors employed by Fonterra or by Danisco, which supplied the strain. A 2018 trial of 228 adults, funded in full by DuPont (HN019's manufacturer at the time, with two authors who were DuPont employees), found no significant difference between HN019 and placebo on its primary endpoint, colonic transit time, or on most secondary measures; only in an after-the-fact subgroup of people with especially infrequent bowel movements at baseline did the combined HN019 doses beat placebo on weekly stool frequency.⁹ A larger trial, 229 adults published in 2024 and funded in full by Danisco/IFF (HN019's current manufacturer, with company employees among the authors), again found no significant difference on its primary endpoint, weekly complete spontaneous bowel movements from baseline to week 8.¹⁰ Because that primary result wasn't significant, the trial's own hierarchical testing plan stopped there; the abdominal pain and bloating differences (P=.04 and P=.02) are labeled nominal, exploratory findings rather than confirmed secondary results, based on a modeled change that left the HN019 group roughly flat while placebo's scores drifted worse.¹⁰ A fourth trial, run across multiple centers and published in 2025 with 224 adults enrolled, also funded by Danisco/IFF with overlapping authors from the 2024 trial, again found HN019 wasn't superior to placebo on the same weekly stool-frequency endpoint.¹¹

Industry sponsored all four trials, and in each one, employees of the funding company co-authored the results. Across the four, only the smallest and oldest trial showed a clear win on its primary transit-time measure; the three larger, more recent trials didn't repeat that on their own primary endpoints. WonderBiotics Probiotics for Gut Health includes HN019 among 12 studied strains at 60 billion CFU total (the individual strain's dose isn't disclosed, so it's not clear how it compares to the doses tested above), positioned as a daily companion for people on GLP-1 medications rather than a fast-acting fix for an active flare-up. The probiotic trials above measured change over 14 to 56 days, while the OTC options below are labeled to act within days: if you haven't had a bowel movement in several days, those are the faster route, and a daily probiotic routine fits better into the weeks and months in between.

How Much Does Movement Help

Regular movement has real, if imperfect, evidence behind it. A 2019 systematic review and meta-analysis of nine randomized trials (680 participants, mostly walking and Qigong-style aerobic movement) found exercise significantly improved constipation symptoms compared with control (RR 1.97, 95% CI 1.19-3.27, P=.009), with a larger effect in the aerobic-exercise-only subgroup (RR 2.42, 95% CI 1.34-4.36, P<.001), though the review authors flagged a high risk of bias across the included trials.¹²

A separate six-month randomized trial of structured resistance and functional-skills training tells a more cautious story: in frail older adults (mean age 81) living in long-term care facilities, where about 22% had constipation at baseline, neither exercise program changed the share of residents with constipation or on laxatives, though this was a secondary outcome without its own reported p-value, and the authors themselves questioned whether their constipation questionnaire was sensitive enough to detect a change.¹³ The two studies didn't test the same population or the same kind of activity, so this isn't proof that frailty blocks the benefit, but it's a reason not to assume movement works the same way for everyone. No trial has tested exercise specifically in people taking semaglutide.

OTC Options: Osmotic Laxatives, Magnesium, and Short-Term Stimulants

When lifestyle changes aren't enough on their own, over-the-counter options step in, but they're not interchangeable, and some are meant for days, not months.

• Polyethylene glycol 3350 (e.g., MiraLax), an osmotic laxative that pulls water into the stool. Its consumer drug information typically takes 2 to 4 days to produce a bowel movement and is labeled for "once a day as needed for up to 2 weeks" without a doctor's involvement.¹⁴
• Magnesium (oxide or citrate), which also works osmotically. For general supplement use, the tolerable upper intake level for adults is 350 mg/day of supplemental magnesium (not counting magnesium naturally in food); NIH's own fact sheet notes that high doses from supplements or medications often cause diarrhea, though laxative products routinely exceed that 350 mg figure by design, since much of that dose isn't absorbed.¹⁵ For laxative use specifically, magnesium oxide's consumer drug information separately warns against using it as a laxative for more than 1 week without medical advice, and anyone with reduced kidney function should check with a doctor first, since impaired kidneys clear excess magnesium less efficiently.¹⁶
• Stimulant laxatives like senna, which work faster but are meant for short-term, occasional use. Its consumer drug information caps unsupervised use at one week.¹⁷
• Stool softeners like docusate, typically slower to act (1 to 3 days) and used short-term by people who need to avoid straining during bowel movements.¹⁸

If you're reaching for any of these more often than the label allows, that's a signal to loop in your prescriber rather than keep escalating on your own. They may adjust your dose, slow your titration schedule, or recommend a longer-term option suited to your situation.

Which Option Fits Your Situation

Use this to figure out where to start, not necessarily where to stop. Many people combine two or three of these rather than relying on just one.

Building a Daily Routine That Fits Your GLP-1 Schedule

For most people, managing semaglutide constipation isn't one single fix; it's layering a couple of these together and adjusting as your dose changes. Hydration and movement are free and low-risk enough to build in as daily habits from the start. A fiber supplement like WonderBiotics Daily Fiber Mix is a reasonable next step once food alone stops closing the gap, precisely because you can start at one sachet and titrate up as your gut adjusts, rather than committing to a full dose on day one.

A daily probiotic routine, such as WonderBiotics Probiotics for Gut Health, fills the slower-acting half of that same habit. We anchored it on HN019 because, of the strains studied for bowel regularity, it has the deepest human research base, four trials and counting, with the clearest single win on transit time and a consistent secondary signal on comfort across the others, which is why it sits alongside 11 other studied strains in a formula built specifically for people managing GLP-1 side effects, not as a fast-acting fix for an active flare. Laxatives fill a different gap: faster, short-term relief once things have already stalled, ideally used with your prescriber's knowledge rather than on an ongoing basis.

When to Call Your Doctor

Constipation from semaglutide is usually uncomfortable rather than dangerous, and it typically responds to the steps above. A few patterns call for medical attention right away instead of another round of home remedies: severe or worsening abdominal pain, a belly that's visibly swollen and not going down, inability to pass gas or stool at all, or persistent vomiting, since these can point to a bowel obstruction.¹⁹ Pain that spreads to your back along with fever, nausea, or vomiting needs prompt care too, since it can signal pancreatitis; steady upper-right abdominal pain lasting several hours, with or without fever, chills, or jaundice, can point to a gallbladder problem instead.^20,21

If constipation has lasted more than two weeks despite fiber, hydration, movement, and an OTC option, or you're using laxatives more often than the label allows, talk to your prescriber. They may adjust your dose, slow your titration schedule, or add a prescription option better suited to your situation than continuing to manage it on your own. Never stop or change your semaglutide dose on your own to deal with constipation; that call belongs to the prescriber tracking your full picture.

References

1. Wegovy (semaglutide) injection prescribing information. DailyMed, setid ee06186f-2aa3-4990-a760-757579d8f77b, Novo Nordisk. DailyMed
2. Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94-105. doi:10.1111/dom.14551. PMID 34514682. doi.org
3. Symptoms & Causes of Constipation. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). niddk.nih.gov/health-information/digestive-diseases/constipation/symptoms-causes. NIDDK
4. Miketinas D, Tucker W, Patterson M, Douglas C. Usual Dietary Fiber Intake in US Adults with Diabetes: NHANES 2013-2018. Curr Dev Nutr. 2021;5(Suppl 2):1061. doi:10.1093/cdn/nzab053_054. Presented at ASN Nutrition Live Online, 2021; summarized in: "Only 7% of US adults meet daily fiber intake recommendation," Healio, June 7, 2021. doi.org
5. Dietary Reference Intakes: Adequate Intake for total fiber. NCBI Bookshelf, DRI Summary Tables, NBK545442, table appJ_tab4. NCBI Bookshelf
6. van der Schoot A, Drysdale C, Whelan K, Dimidi E. The effect of fiber supplementation on chronic constipation in adults: an updated systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2022;116(4):953-969. PMC9535527. PMC
7. Noack J, Timm D, Hospattankar A, Slavin J. Fermentation Profiles of Wheat Dextrin, Inulin and Partially Hydrolyzed Guar Gum Using an In Vitro Digestion Pretreatment and In Vitro Batch Fermentation System Model. Nutrients. 2013;5(5):1500-1510. PMC3708332. PMC
8. Waller PA, Gopal PK, Leyer GJ, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-1064. PMID 21663486. PubMed
9. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes. 2018;9(3):236-251. doi:10.1080/19490976.2017.1412908. PMID 29227175. doi.org
10. Cheng J, Gao C, Ala-Jaakkola R, et al. Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial. JAMA Netw Open. 2024;7(10):e2436888. doi:10.1001/jamanetworkopen.2024.36888. PMID 39356506. doi.org
11. Ala-Jaakkola R, Forssten SD, Cheng J, et al. Effect of an 8-Week Bifidobacterium lactis HN019 Supplementation on Functional Constipation: A Multi-Center, Triple-Blind, Randomized, Placebo-Controlled Trial. Mol Nutr Food Res. 2025;69(17):e70081. doi:10.1002/mnfr.70081. PMID 40320938. doi.org
12. Gao R, Tao Y, Zhou C, Li J, Wang X, Chen L, Li F, Guo L. Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2019;54(2):169-177. PMID 30843436. PubMed
13. Chin A Paw MJM, van Poppel MNM, van Mechelen W. Effects of resistance and functional-skills training on habitual activity and constipation among older adults living in long-term care facilities: a randomized controlled trial. BMC Geriatrics. 2006;6:9. PMID 16875507. PubMed
14. Polyethylene Glycol 3350. MedlinePlus Drug Information. medlineplus.gov/druginfo/meds/a603032.html. MedlinePlus
15. Magnesium - Health Professional Fact Sheet. NIH Office of Dietary Supplements. ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/. NIH ODS
16. Magnesium Oxide. MedlinePlus Drug Information. medlineplus.gov/druginfo/meds/a601074.html. MedlinePlus
17. Senna. MedlinePlus Drug Information. medlineplus.gov/druginfo/meds/a601112.html. MedlinePlus
18. Stool Softeners (Docusate). MedlinePlus Drug Information. medlineplus.gov/druginfo/meds/a601113.html. MedlinePlus
19. Intestinal Obstruction. MedlinePlus Medical Encyclopedia. medlineplus.gov/ency/article/000260.htm. MedlinePlus
20. Pancreatitis - Symptoms & Causes. NIDDK. niddk.nih.gov/health-information/digestive-diseases/pancreatitis/symptoms-causes. NIDDK
21. Gallstones - Symptoms & Causes. NIDDK. niddk.nih.gov/health-information/digestive-diseases/gallstones/symptoms-causes. NIDDK